|
Michel Bazinet M.D., 50, was appointed a director of the Corporation effective July 9, 2004. Since January 2003, Dr. Bazinet has been Chairman & CEO of privately held Replicor, Inc., which develops new antiviral and anticancer therapies. Prior to his involvement with Replicor, from 1996 to 2000, Dr. Bazinet was the founder and medical director of Mediconsult, a healthcare knowledge company. Mediconsult completed its initial public offering in 1999 and was ultimately acquired by The Cybear Group in 2000. Dr. Bazinet, a board-certified urologist, received his MD from Sherbrooke University. He completed his residency at McGill University, Montreal, and has been a research fellow at Memorial Sloan-Kettering Cancer Center, New York. Dr. Bazinet, a former assistant professor of both urology and oncology at McGill University, is also an accomplished speaker, medical industry author and consultant. Other Directorships: Bioniche Life Sciences Inc. | 